Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Julphar
Healthtrust
Moodys
Citi
Dow
Novartis
McKinsey
Fish and Richardson
US Army

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020997

« Back to Dashboard

NDA 020997 describes CHIROCAINE, which is a drug marketed by Purdue Pharma Lp and is included in one NDA. Additional details are available on the CHIROCAINE profile page.

The generic ingredient in CHIROCAINE is levobupivacaine hydrochloride. Additional details are available on the levobupivacaine hydrochloride profile page.
Summary for 020997
Tradename:CHIROCAINE
Applicant:Purdue Pharma Lp
Ingredient:levobupivacaine hydrochloride
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 2.5MG BASE/ML
Approval Date:Aug 5, 1999TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 5MG BASE/ML
Approval Date:Aug 5, 1999TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 7.5MG BASE/ML
Approval Date:Aug 5, 1999TE:RLD:No

Expired US Patents for NDA 020997

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Purdue Pharma Lp CHIROCAINE levobupivacaine hydrochloride INJECTABLE;INJECTION 020997-001 Aug 5, 1999 ➤ Subscribe ➤ Subscribe
Purdue Pharma Lp CHIROCAINE levobupivacaine hydrochloride INJECTABLE;INJECTION 020997-002 Aug 5, 1999 ➤ Subscribe ➤ Subscribe
Purdue Pharma Lp CHIROCAINE levobupivacaine hydrochloride INJECTABLE;INJECTION 020997-003 Aug 5, 1999 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Mallinckrodt
Dow
Boehringer Ingelheim
Teva
Baxter
Fuji
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot